CHIMERIX INC. - COMMON STOCK

Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update

03 Aug 2023 06:00:00 By Nasdaq GlobeNewswire

Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023

27 Jul 2023 06:00:01 By Nasdaq GlobeNewswire

Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer

27 Jun 2023 15:05:00 By Nasdaq GlobeNewswire

Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference

31 May 2023 15:01:00 By Nasdaq GlobeNewswire

Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House

25 May 2023 06:00:00 By Nasdaq GlobeNewswire

Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update

04 May 2023 06:00:01 By Nasdaq GlobeNewswire

Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023

27 Apr 2023 06:00:01 By Nasdaq GlobeNewswire

Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting

18 Apr 2023 15:01:00 By Nasdaq GlobeNewswire

Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update

02 Mar 2023 06:00:01 By Nasdaq GlobeNewswire

Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference

28 Feb 2023 15:05:01 By Nasdaq GlobeNewswire

Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023

23 Feb 2023 06:00:01 By Nasdaq GlobeNewswire

Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference

05 Jan 2023 06:00:00 By Nasdaq GlobeNewswire

Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update

08 Dec 2022 16:00:00 By Nasdaq GlobeNewswire

Chimerix Responds to Rubric Capital Management

10 Nov 2022 15:30:00 By Nasdaq GlobeNewswire

Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update

03 Nov 2022 06:00:02 By Nasdaq GlobeNewswire

Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022

27 Oct 2022 15:30:00 By Nasdaq GlobeNewswire

Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions

26 Sep 2022 15:05:00 By Nasdaq GlobeNewswire

Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference

06 Sep 2022 06:00:01 By Nasdaq GlobeNewswire

Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox

29 Aug 2022 09:45:00 By Nasdaq GlobeNewswire

Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update

08 Aug 2022 15:01:00 By Nasdaq GlobeNewswire